Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT
Conditions: Ankle Fractures Interventions: Drug: subcutaneous Teriparatide injection; Other: placebo Sponsors: University of Calgary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Precision Medicine Approach for Osteoporosis - Follow Up Study
Conditions: Osteoporosis Interventions: Drug: Alendronate; Drug: Teriparatide; Drug: Alendronate Sponsors: Hartmut Malluche, MD Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Sequential Therapies After Osteoanabolic Treatment
Conditions: Osteoporosis, Postmenopausal Interventions: Drug: Zoledronate; Drug: Denosumab; Drug: Teriparatide; Drug: Romosozumab Sponsors: 424 General Military Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials

Teriparatide on Maxillary Sinus Floor Osseointegration
Conditions: Bone Regeneration Interventions: Drug: Teriparatide; Procedure: Maxillary Sinus Augmentation; Procedure: Dental Implant Installation; Combination Product: Bone graft Sponsors: Universidad de Valparaiso; Universidade Federal Fluminense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
Condition:   Hypoparathyroidism Interventions:   Drug: EBP05;   Drug: Forteo 20 mg;   Drug: EBP11;   Drug: EBP22;   Drug: EBP11-M Sponsor:   Entera Bio Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Condition:   Osteoporotic Fractures Interventions:   Drug: Denosumab;   Drug: Teriparatide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2023 Category: Research Source Type: clinical trials